MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

A

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

A

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

A

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

A

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

A

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

Search

Pacific Biosciences of California Inc

Closed

SectorHealthcare

1.48 15.62

Overview

Share price change

24h

Current

Min

1.28

Max

1.48

Key metrics

By Trading Economics

Income

-428M

-426M

Sales

-2.1M

37M

Profit margin

-1,146.812

Employees

575

EBITDA

-420M

-403M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+67.44% upside

Dividends

By Dow Jones

Next Earnings

6 sie 2025

Market Stats

By TradingEconomics

Market Cap

51M

390M

Previous open

-14.14

Previous close

1.48

News Sentiment

By Acuity

13%

87%

14 / 380 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Pacific Biosciences of California Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 lip 2025, 17:03 UTC

Major Market Movers

Furniture Companies Rise on U.S. Trade Deal With Vietnam

2 lip 2025, 15:18 UTC

Major Market Movers

Mogo Shares Rally After Embrace of Bitcoin Into Holdings, Operations

2 lip 2025, 23:45 UTC

Market Talk

Global Equities Roundup: Market Talk

2 lip 2025, 23:45 UTC

Market Talk

Nikkei May Trade Rangebound Amid U.S. Tariff Uncertainty -- Market Talk

2 lip 2025, 23:40 UTC

Market Talk

Gold Edges Lower Amid Hopes for More Trade Deals -- Market Talk

2 lip 2025, 21:01 UTC

Acquisitions, Mergers, Takeovers

AT&T Completes Sale of Entire Remaining 70% Stake in DIRECTV to TPG >T

2 lip 2025, 21:01 UTC

Acquisitions, Mergers, Takeovers

AT&T and TPG Close DIRECTV Transaction

2 lip 2025, 20:26 UTC

Earnings

Rivian Stock Drops on Sales Decline. The Stakes Are High for the Rest of 2025. -- Barrons.com

2 lip 2025, 20:22 UTC

Market Talk

Gold Rises Following Weak ADP Payroll Reading -- Market Talk

2 lip 2025, 20:13 UTC

Market Talk

Oil Price Expectations Stable in Dallas Fed Survey -- Market Talk

2 lip 2025, 19:09 UTC

Market Talk

Oil Futures Bounce in Defiance of Downbeat Data -- Market Talk

2 lip 2025, 19:08 UTC

Market Talk

Dollar Trims Gains as Investors Brace for Cooling Jobs Market -- Market Talk

2 lip 2025, 19:01 UTC

Market Talk

U.S. Natural Gas Ticks Up Ahead of Storage Data -- Market Talk

2 lip 2025, 18:08 UTC

Market Talk

Fossil Fuels Rule Energy Roost As U.S. Marks Independence -- Market Talk

2 lip 2025, 17:06 UTC

Acquisitions, Mergers, Takeovers

BCE: Maple Leafs, Raptors Rights Access Through Long-Term Agreement With Rogers, Subject to League Approvals

2 lip 2025, 17:05 UTC

Acquisitions, Mergers, Takeovers

BCE: Access to Content Rights for Toronto Maple Leafs, Toronto Raptors on TSN Secured Through 2043/2044 Season

2 lip 2025, 17:04 UTC

Acquisitions, Mergers, Takeovers

BCE: Proceeds of MLSE Stake Sale to Support Financing of Acquisition of Ziply Fiber

2 lip 2025, 17:04 UTC

Acquisitions, Mergers, Takeovers

BCE Inc. Concludes Sale of Minority Stake in Maple Leaf Sports & Entertainment

2 lip 2025, 17:02 UTC

Acquisitions, Mergers, Takeovers

Rogers Communications: Now Largest Owner With 75% Interest in Maple Leaf Sports & Entertainment

2 lip 2025, 17:02 UTC

Acquisitions, Mergers, Takeovers

Rogers Communications Closes Deal to Buy BCE's 37.5% Stake in Maple Leaf Sports & Entertainment for C$4.7B

2 lip 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

2 lip 2025, 16:20 UTC

Market Talk

Cushing Crude Stock Slide Keeps Bid in WTI -- Market Talk

2 lip 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

2 lip 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

2 lip 2025, 16:11 UTC

Market Talk

Copper Prices Hold Higher on Supply Disruption, Tariff Uncertainty -- Market Talk

2 lip 2025, 16:09 UTC

Market Talk

Gold Futures Rise, Recouping Some Losses -- Market Talk

2 lip 2025, 15:59 UTC

Earnings

These Stocks Are Moving the Most Today: Tesla, Centene, Apple, Adobe, Rigetti Computing, Greenbrier, and More -- Barrons.com

2 lip 2025, 15:17 UTC

Market Talk

Oil Market to Keep Close Watch on U.S. Payrolls -- Market Talk

2 lip 2025, 15:08 UTC

Market Talk

Luxury Sector Should Report a Slowdown -- Market Talk

2 lip 2025, 15:00 UTC

Acquisitions, Mergers, Takeovers

Glencore: Merger of Viterra With Bunge Global Closed

Peer Comparison

Price change

Pacific Biosciences of California Inc Forecast

Price Target

By TipRanks

67.44% upside

12 Months Forecast

Average 2.16 USD  67.44%

High 3 USD

Low 1.25 USD

Based on 8 Wall Street analysts offering 12 month price targets forPacific Biosciences of California Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

5

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

1.13 / N/ASupport & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

14 / 380 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Pacific Biosciences of California Inc

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.